Literature DB >> 27376549

Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Karmel A Allison1,2, Eniko Sajti3,4, Jana G Collier1, David Gosselin1, Ty Dale Troutman1, Erica L Stone5,6, Stephen M Hedrick1,5, Christopher K Glass1,7.   

Abstract

Affinity and dose of T cell receptor (TCR) interaction with antigens govern the magnitude of CD4+ T cell responses, but questions remain regarding the quantitative translation of TCR engagement into downstream signals. We find that while the response of mouse CD4+ T cells to antigenic stimulation is bimodal, activated cells exhibit analog responses proportional to signal strength. Gene expression output reflects TCR signal strength, providing a signature of T cell activation. Expression changes rely on a pre-established enhancer landscape and quantitative acetylation at AP-1 binding sites. Finally, we show that graded expression of activation genes depends on ERK pathway activation, suggesting that an ERK-AP-1 axis plays an important role in translating TCR signal strength into proportional activation of enhancers and genes essential for T cell function.

Entities:  

Keywords:  computational biology; enhancers; immunology; mouse; protein kinase; systems biology; transcription factors

Mesh:

Substances:

Year:  2016        PMID: 27376549      PMCID: PMC4931909          DOI: 10.7554/eLife.10134

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  88 in total

1.  MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.

Authors:  Laura J Vella; Anupama Pasam; Nektaria Dimopoulos; Miles Andrews; Ashley Knights; Anne-Laure Puaux; Jamila Louahed; Weisan Chen; Katherine Woods; Jonathan S Cebon
Journal:  Cancer Immunol Res       Date:  2014-01-17       Impact factor: 11.151

2.  Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.

Authors:  P R Rogers; H M Grey; M Croft
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

3.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

4.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

5.  Functional consequences of engagement of the T cell receptor by low affinity ligands.

Authors:  J Alexander; K Snoke; J Ruppert; J Sidney; M Wall; S Southwood; C Oseroff; T Arrhenius; F C Gaeta; S M Colón
Journal:  J Immunol       Date:  1993-01-01       Impact factor: 5.422

6.  Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins.

Authors:  S M Hedrick; E A Nielsen; J Kavaler; D I Cohen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

7.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

8.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

9.  The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells.

Authors:  Francesco Marangoni; Thomas T Murooka; Teresa Manzo; Edward Y Kim; Esteban Carrizosa; Natalie M Elpek; Thorsten R Mempel
Journal:  Immunity       Date:  2013-01-11       Impact factor: 31.745

10.  Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation.

Authors:  E Heber-Katz; R H Schwartz; L A Matis; C Hannum; T Fairwell; E Appella; D Hansburg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? Epigenome: A Dynamic Vehicle for Transmitting and Recording Cytokine Signaling.

Authors:  John L Johnson; Golnaz Vahedi
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

2.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 3.  Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.

Authors:  Masahiro Ono
Journal:  Immunology       Date:  2020-03-09       Impact factor: 7.397

4.  Multidimensional quantitative analysis of mRNA expression within intact vertebrate embryos.

Authors:  Vikas Trivedi; Harry M T Choi; Scott E Fraser; Niles A Pierce
Journal:  Development       Date:  2018-01-08       Impact factor: 6.868

5.  TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2.

Authors:  Dmitri I Kotov; Jason S Mitchell; Thomas Pengo; Christiane Ruedl; Sing Sing Way; Ryan A Langlois; Brian T Fife; Marc K Jenkins
Journal:  J Immunol       Date:  2019-03-11       Impact factor: 5.422

6.  Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density.

Authors:  John R James
Journal:  Sci Signal       Date:  2018-05-22       Impact factor: 8.192

7.  Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.

Authors:  Justin Eyquem; Jorge Mansilla-Soto; Theodoros Giavridis; Sjoukje J C van der Stegen; Mohamad Hamieh; Kristen M Cunanan; Ashlesha Odak; Mithat Gönen; Michel Sadelain
Journal:  Nature       Date:  2017-02-22       Impact factor: 49.962

8.  Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.

Authors:  Mikhail Binnewies; Adriana M Mujal; Joshua L Pollack; Alexis J Combes; Emily A Hardison; Kevin C Barry; Jessica Tsui; Megan K Ruhland; Kelly Kersten; Marwan A Abushawish; Marko Spasic; Jonathan P Giurintano; Vincent Chan; Adil I Daud; Patrick Ha; Chun J Ye; Edward W Roberts; Matthew F Krummel
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

9.  Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity.

Authors:  Lan Luo; Yuhong Chen; Xiao Chen; Yongwei Zheng; Vivian Zhou; Mei Yu; Robert Burns; Wen Zhu; Guoping Fu; Juan C Felix; Christopher Hartley; Alisa Damnernsawad; Jing Zhang; Renren Wen; Williams R Drobyski; Chunji Gao; Demin Wang
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

Review 10.  Epigenetic and transcriptional mechanisms for the regulation of IL-10.

Authors:  Huiyuan Zhang; Vijay Kuchroo
Journal:  Semin Immunol       Date:  2019-10-30       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.